$XOMA

Hernday Natasha sold (to issuer) 4,000 shares of XOMA

Hernday Natasha sold (to issuer) 4,000 shares of XOMA Royalty Corp (XOMA) on 2026-07-14.

Original reporting
SEC EDGAR · Hernday Natasha
Published Jul 15, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$XOMA
Neutral
high confidence
Mentioned
$XOMA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XOMANeutralLow
01

Why it matters

A director sold 4,000 shares to the issuer; no 10b5-1 plan is indicated and no other corporate developments are included.

02

Market read

Traders may note the latest insider activity, but the filing provides limited actionable information due to undisclosed price/value and lack of accompanying fundamental catalysts.

03

What to watch

Because the price and total value are not disclosed, the economic magnitude of the sale cannot be assessed, reducing interpretability.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-14 after-hours; reflects latest insider activity for XOMA.

Background

The article is an SEC Form 4 insider transaction disclosure for XOMA Royalty Corp.

Company-level read

Ticker impact

$XOMANeutralHigh confidence
Context

SEC Form 4 shows director Hernday Natasha sold 4,000 XOMA shares to the issuer on 2026-07-14, with price undisclosed.

Expected impact

Low likelihood of a sustained price move solely from this filing; any reaction would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but the transaction value and price are not disclosed and there is no 10b5-1 plan or other new corporate event described.

Market effects

No sector read-across; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

Issuer-sale transactions can be mechanical (e.g., buyback participation) and may not reflect bearish expectations.

Key entities

  • XOMA Royalty Corp

    Company whose shares were sold by a director to the issuer per SEC Form 4.

  • Hernday Natasha

    Director who sold 4,000 shares to the issuer on 2026-07-14.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LGNDMedAI 9/10

XOMA Royalty Announces Closing of Its Acquisition by Ligand

XOMA Royalty said Ligand Pharmaceuticals (Nasdaq: LGND) completed its acquisition of XOMA Royalty. Under the April 27 deal, XOMA shareholders received $39.00 cash per share and one non-transferable CVR per share tied to 75% of net proceeds from certain pending litigation. XOMA shares no longer trade on Nasdaq.

$LAURMed

Snow Ian Kendell sold $19.1M of LAUR (indirect holdings)

Snow Ian Kendell sold 521,229 indirectly-held shares of LAUREATE EDUCATION, INC. (LAUR) at an average of $36.65 ($36.26–$38.43, $19.10M total) across 3 trades over 2026-08-31 to 2026-09-02. Filed jointly with Snow Phipps Group (RPV), L.P. (Director), Snow Phipps Group (Offshore), L.P. (Director), SPG Co-Investment, L.P. (Director), Snow Phipps Group (B), L.P. (Director), Snow Phipps Group, L.P. (Director) and Snow Phipps Group, LLC (Director).